We Made Five Predictions For Clinical Research Last Year. Here's What Happened

As AI-driven drug discovery accelerates, clinical trial execution is hitting a procedural wall. This retrospective analysis by Mural Health evaluates the accuracy of their 2025 industry predictions, revealing that while pipelines are scaling, site-level operations are struggling under a 42% increase in procedures and a 37% rise in endpoints. This piece will help you to navigate the transition from "talking" about patient-centricity to "operationalizing" it for 2026. Through these insights, sponsors and clinical ops leaders can better understand why trial starts aren't keeping pace with discovery and how to leverage financial support as a strategic advantage. It also enables regulatory professionals to track the shifting FDA standards regarding participant experience data. Site managers will gain data-backed insights into the rising complexity of Phase III protocols and new tools for financial management.